Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 520 (RNA5SP520) is a processed pseudogene derived from the 5S ribosomal RNA gene family[5][4]. Unlike functional 5S rRNA, which is a component of the large ribosomal subunit and crucial to protein synthesis[1][3], this pseudogene does not code for functional RNA or protein due to disabling mutations or loss of regulatory elements acquired during its evolutionary history[2][4]. Processed pseudogenes, such as RNA5SP520, are typically generated by reverse transcription of an RNA transcript followed by integration into a new genomic locus, lacking introns and functional promoters[2][4]. While there is growing evidence that pseudogenes as a class may exert regulatory effects—such as acting as decoys for miRNAs or by affecting the expression of their cognate parental genes in cancer and other contexts—there are no specific data implicating RNA5SP520 in these roles or as a biomarker or therapeutic target in any disease context to date[6]. It should not be considered a drug target, receptor, enzyme, transporter, or other canonical therapeutic target family member.
None known (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 520 (RNA5SP520).